Related Experiment Video
Updated: Mar 21, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
Published on: September 30, 2017
Tularemia vaccines
Daniela Putzova1, Iva Senitkova1, Jiri Stulik2
1Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic.
Francisella tularensis causes tularemia, a dangerous disease. This review explores current and novel vaccine candidates, addressing the urgent need for a safe and effective Francisella tularensis vaccine.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Francisella tularensis is a highly infectious bacterium responsible for tularemia.
- It is classified as a Category A bioterrorism agent due to its low infectious dose and aerosol transmission.
- Currently, no fully licensed and safe vaccine is available for public use.
Purpose of the Study:
- To review existing and emerging vaccine candidates against Francisella tularensis.
- To highlight the limitations of current vaccine approaches.
- To discuss the potential of live attenuated and subunit vaccines.
Main Methods:
- Literature review of existing and novel vaccine research.
- Analysis of vaccine candidate characteristics and efficacy data.
- Synthesis of information on attenuated and subunit vaccine strategies.
Main Results:
- Existing live attenuated vaccine candidates have not met general use criteria.
- Novel vaccine strategies are under development.
- Both live attenuated and subunit vaccine approaches show promise.
Conclusions:
- There is a critical need for a safe and effective Francisella tularensis vaccine.
- Further research into both live attenuated and subunit vaccines is warranted.
- Development of a licensed vaccine is crucial for public health protection against tularemia.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Vaccinations
Vaccines
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...